Effectiveness of hepatic artery infusion (HAI) vs selective internal radiation therapy (Y90) for pretreated isolated unresectable colorectal liver metastases (IU-CRCLM)
Annals of Surgical Oncology Jan 25, 2018
Dhir M, et al. - Authors aimed at comparing the overall survival (OS) after HAI vs Y90 for IU-CRCLM patients treated with modern chemotherapy. In addition, they performed a cost analysis of both regional methods. The findings revealed that for patients with pretreated IU-CRCLM, HAI was associated with better survival than Y90. Furthermore, a trend toward reduced cost favored the HAI group.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
